Akinobu Furutani
- Oncology top 10%
- Colorectal Cancer Surgical Treatments 12
- Colorectal Cancer Screening and Detection 4
- Pancreatic and Hepatic Oncology Research 3
-
- Colorectal and Anal Carcinomas 9
- Esophageal Cancer Research and Treatment 4
- Gastrointestinal disorders and treatments 3
- Anorectal Disease Treatments and Outcomes 3
-
- Gastric Cancer Management and Outcomes 4
Akinobu Furutani
31 papers receiving 373 citations
Peers
Comparison fields: 5 of 53
- Oncology 292
- Surgery 263
- Pulmonary and Respiratory Medicine 92
- Internal Medicine 10
- Cancer Research 26
Countries citing papers authored by Akinobu Furutani
This map shows the geographic impact of Akinobu Furutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinobu Furutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinobu Furutani more than expected).
Fields of papers citing papers by Akinobu Furutani
This network shows the impact of papers produced by Akinobu Furutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinobu Furutani. The network helps show where Akinobu Furutani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akinobu Furutani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2020 | 2 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 40 | |
| 5 | 2018 | 56 | |
| 6 | 2017 | 21 | |
| 7 | 2017 | 25 | |
| 8 | 2017 | 7 | |
| 9 | 2016 | 15 | |
| 10 | 2016 | 2 | |
| 11 | 2015 | 0 | |
| 12 | Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma. | 2013 | 17 |
| 13 | 2013 | 1 | |
| 14 | Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. | 2011 | 37 |
| 15 | 2008 | 4 | |
| 16 | 2008 | 2 | |
| 17 | 2008 | 1 | |
| 18 | 2006 | 2 | |
| 19 | 2005 | 24 | |
| 20 | 1996 | 5 |
About Akinobu Furutani
Akinobu Furutani is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 380 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (12 papers), Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Screening and Detection (4 papers), Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Gastrointestinal disorders and treatments (3 papers), Anorectal Disease Treatments and Outcomes (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (292 citations), Surgery (263 citations) and Pulmonary and Respiratory Medicine (92 citations). Akinobu Furutani has collaborated with scholars based in Japan, France and Russia. Frequent co-authors include Tomohiro Yamaguchi, Yusuke Kinugasa, Yushi Yamakawa, Hiroyasu Kagawa, Akio Shiomi, Yusuke Yamaoka, Shoichi Manabe, Masakatsu Numata, Hitoshi Hino and Hitoshi Fujiwara. Their work appears in journals such as Surgical Endoscopy, International Journal of Colorectal Disease, Journal of Clinical Oncology, Anticancer Research and Esophagus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.